$MMED Balance Sheet | Understand Stock

$MMED

$18.93 +$0.27 (1.45%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q1 FY2027 As of Jul 31, 2026	Q4 FY2026 As of Apr 24, 2026	Q3 FY2026 As of Jan 23, 2026
ASSETS
Current assets:
Cash and cash equivalents
Accounts receivable, less allowance for credit losses of $28 and $26, respectively
Due from Medtronic
Inventories
Other current assets
Total current assets
Property, plant, and equipment, net
Goodwill
Other intangible assets, net
Tax assets
Other assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued compensation
Accrued rebates
Other accrued expenses
Related Party
Nonrelated Party
Total other accrued expenses
Total current liabilities
Other liabilities
Total liabilities
Stockholders’ equity:
Common stock, par value $0.01, 1,000,000,000 shares authorized, 281,205,548 and 280,819,988 shares issued and outstanding, at July 31, 2026 and April 24, 2026, respectively
Preferred stock, par value $0.01, 100,000,000 shares authorized, none issued and outstanding
Additional paid-in capital
Accumulated deficit
Net parent investment
Accumulated other comprehensive income
Total stockholders’ equity
Noncontrolling interests
Total equity
Total liabilities and stockholders’ equity

Comments